FindTrial
Sign In

Role of certain blood tests(serum TWEAK and hematologic markers) in predicting the severity of acute pancreatitis

Role of serum tumor necrosis factor like weak inducer of apoptosis (TWEAK) and hematological markers in predicting the severity of acute pacreatitis - an observational study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2020/01/022591
Enrollment
184
Registered
2020-01-02
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K85- Acute pancreatitis

Interventions

None listed

Sponsors

JIPMER intrumural fund
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: All patients over the age of 18 with acute pancreatitis presenting within 72 hours of onset of symptoms, admitted to the surgery emergency will be included in the study.

Exclusion criteria

Exclusion criteria: patients on antiplatelet therapy, autoimmune diseases, hematologic diseases, HIV positive and patients on immunosuppression will be excluded from the study.

Design outcomes

Primary

MeasureTime frame
THE PRIMARY OUTCOME VARIABLES ARE values of serum TWEAK, Immature granulocyte percentage, Neutrophil to lymphocyte ratio and mean platelet volume.Timepoint: the time points include blood investigations at admission and 24 hours after admission—

Secondary

MeasureTime frame
THE SECONDARY OUTCOME VARIABLE IS THE VALUES OF SERUM PROALCITONINTimepoint: NO APPLICABLE—

Countries

India

Contacts

Public ContactSarath Chandra Sistla

JIPMER

sarathsistla@hotmail.com9894013556

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026